Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Annals of Surgical Oncology|January 25, 2018
Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer AdenocarcinomaStéphane Renaud, Joseph Seitlinger, Francesco Guerrera, et al.
Biomedicines|May 28, 2022
Vascularization of Patient-Derived Tumoroid from Non-Small-Cell Lung Cancer and Its MicroenvironmentJoseph Seitlinger, Anasse Nounsi, Ysia Idoux-Gillet, et al.
Journal of Thoracic Disease|December 11, 2025
The effect of lobar versus sublobar video-assisted thoracoscopic surgery lung resection on patient quality of lifeLyndon C Walsh, Joseph Seitlinger, Morgan S Gold, et al.
Clinical Lung Cancer|July 9, 2025
KRAS ctDNA Detection in Patients With Resectable Lung AdenocarcinomaMeghan L De Meo, Joseph Seitlinger, Roni F Rayes, et al.
Biomedicines|July 29, 2023
Patient-Derived Tumoroid for the Prediction of Radiotherapy and Chemotherapy Responses in Non-Small-Cell Lung CancerAnasse Nounsi, Joseph Seitlinger, Charlotte Ponté, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 8, 2025
VALUE Trial: Phase 1 safety and feasibility study of same-day discharge after video-assisted thoracoscopic surgery lung resectionLyndon C Walsh, Merav Rokah, Joseph Seitlinger, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 26, 2025
The outcomes of salvage surgery for non-small cell lung cancer after immune checkpoint inhibitor or targeted therapy treatment. A multi-center international real-life studyFrancesco Guerrera, Filippo Lococo, Ludovic Fournel, et al.
The Annals of Thoracic Surgery|December 17, 2020
Safety and Feasibility of Thoracic Malignancy Surgery During the COVID-19 PandemicJoseph Seitlinger, Christophe Wollbrett, Antonio Mazzella, et al.
Clinical Lung Cancer|February 20, 2024
Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology NetworkYohann Pilon, Merav Rokah, Joseph Seitlinger, et al.
The Annals of Thoracic Surgery|October 30, 2025
Neoadjuvant Chemotherapy-Immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography Scan Predict Complete Pathologic Response?Joseph Seitlinger, Olivier Salko, Luciano Bulgarelli Maqueda, et al.
Pageof 4